Abstract: Code designs for channel coding with side information (CCSI) based on combined source-channel coding are disclosed. These code designs combine trellis-coded quantization (TCQ) with irregular repeat accumulate (IRA) codes. The EXIT chart technique is used for IRA channel code design (and especially for capacity-approaching IRA channel code design). We emphasize the role of strong source coding and endeavor to achieve as much granular gain as possible by using TCQ. These code designs synergistically combine TCQ with IRA codes. By bringing together TCQ and EXIT chart-based IRA code designs, we are able to approach the theoretical limit of dirty-paper coding.

Abstract: In accordance with particular embodiments, a desalination system includes a plurality of evaporators. The plurality of evaporators includes at least a first evaporator and a last evaporator. The plurality of evaporators are arranged in cascading fashion such that a concentration of salt in a brine solution increases as the brine solution passes through the plurality of evaporators from the first evaporator towards the last evaporator. The desalination system also includes a plurality of heat exchangers. An input of each evaporator is coupled to at least one of the plurality of heat exchangers. The system also includes a vapor source coupled to at least one of the plurality of evaporators.

Abstract: Method and apparatus are disclosed for recovering natural gas from a hydrate deposit near or at the sea floor. A rigid dome structure, supported by a floating vessel and movable along the sea floor, is placed over the hydrate deposit. Heated sea water may be pumped from the floating vessel through headers and nozzles in the rigid dome structure. The heated sea water preferably fluidizes the marine sand containing hydrate, releasing gas in the hydrate. The gas is collected in the rigid dome structure and moved through a pipe to the floating vessel, where it may be processed through a turbo-expander and liquefied.

Abstract: The present invention relates in general to therapeutic compositions and methods of use. In preferred embodiments, the invention relates to the field of eye health. In some embodiments, the invention relates to the prevention and treatment of macular degeneration by administering compounds disclosed herein. In some embodiments, the invention relates to compositions and methods of improving vision.

Abstract: A method of producing alcohols, hydrocarbons, or both from biomass by converting biomass into a carboxylic acid, reacting the carboxylic acid with an olefin to produce an ester and hydrogenolyzing the ester to produce alcohol. A method of producing hydrocarbons from biomass by converting at least a portion of the biomass into a carboxylic acid, a ketone, or an ammonium carboxylate salt, reacting at least one of a portion of the carboxylic acid, a portion of the ketone, or a portion of the ammonium carboxylate salt in an oligomerization reactor as at least part of a process that produces an oligomerization product and separating hydrocarbons from the oligomerization product.

Abstract: We investigate error-correcting codes for a novel storage technology, which we call the rank-modulation scheme. In this scheme, a set of n cells stores information in the permutation induced by the different levels of the individual cells. The resulting scheme eliminates the need for discrete cell levels, and overshoot errors when programming cells (a serious problem that reduces the writing speed), as well as mitigates the problem of asymmetric errors. In this discussion, the properties of error correction in rank modulation codes are studied. We show that the adjacency graph of permutations is a subgraph of a multi-dimensional array of a special size, a property that enables code designs based on Lee-metric codes and L1-metric codes. We present a one-error-correcting code whose size is at least half of the optimal size. We also present additional error-correcting codes and some related bounds.

Abstract: A method of enhancing expression of at least one desired gene product in a plant, comprises transgenically introducing a Tombusvirus p19/R43W mutant gene (SEQ. ID NO: 3) into the plant, expressing at least one desired gene product in the plant, wherein expression of said product is susceptible to RNA silencing; and co-expressing the transgenically introduced p19/R43W, to produce an amount of P19/R43W mutant protein (SEQ. ID NO: 4) sufficient to suppress silencing of expression of said desired gene product.

Abstract: The present invention provides organic arsenicals which may be used to treat numerous human tumor cell lines, both of solid and hematological origin, as well as against malignant blood cells from patients with leukemia.

Abstract: According to one embodiment, a guideway switching mechanism includes an elongated section of flexible guideway coupled to a switch plate. The flexible guideway has a first end that may be coupled to a first elongated guideway and a second end that may be selectively coupled to one of a multiple quantity of alternative guideways. The switch plate provides selective coupling of the flexible guideway to multiple alternative guideways by movement through an arcuate path such that the automated transport vehicle may selectively move from the first elongated guideway to either of the alternative guideways.

Abstract: According to one embodiment, a pair of guideway engagement members having a controller circuit is configured on a transport vehicle that travels over an elongated guideway. The pair of guideway engagement members have a corresponding pair of bearing members that are each disposed on opposing sides of the guideway. The controller circuit receives a measurement indicative of dynamic movement of the transport vehicle from one or more sensors, and adjusts the stiffness of the pair of guideway engagement members according to the measurements received from the sensors.

Abstract: Disclosed are antibodies that block the binding of fibronectin protein to fibronectin. Also disclosed are site specifically-mutated and truncated peptide epitopes derived from the fnbA and fnbB genes of Staphylococcus aureus, the fnbA and fnbB genes of Streptococcus dysgalactiae, and the sfb gene of Streptococcus pyogenes, and nucleic acid segments encoding these peptides and epitopes. The anti-(fibronectin binding site) antibodies, peptides and epitopes that give rise to antibodies that block the binding of fibronectin binding proteins to fibronectin, and DNA segments encoding these proteins and are of use in various screening, diagnostic and therapeutic applications including active and passive immunization and methods for the prevention of streptococcal and staphylococcal colonization in animals or humans. These. DNA segments and the peptides derived therefrom are proposed to be of use directly in the preparation of vaccines and also for use as carrier proteins in vaccine formulations.

Abstract: An encoder employs a trellis coded quantization (TCQ) unit and a compression unit. The TCQ uses a set of polynomials that have been selected to maximize granular gain. The TCQ unit operates on a block of samples from a source. The compression unit compresses bit planes of the TCQ output, using parity check matrices of corresponding LDPC codes, to obtain corresponding syndromes. The parity check matrices are selected so their compression performance approaches close to the limit for Slepian-Wolf coding. A decoder employs a decoding unit and an estimation unit. The decoding unit decodes the syndromes using side information to produce an estimate for the TCQ output. The side information is correlated with the source. The estimation unit estimates the block of source samples using the estimated TCQ output and the side information. Trellis coded vector quantization may be used as an alternative to TCQ.

Abstract: The present invention includes compositions and methods for the use of an encapsulation additive having between about 0.1 to about 30 percent isolated and purified vitelline protein B to provide for mixed and extended release formulations.

Abstract: A dispersible nanocomposite comprising nanotubes associated with nanoplatelets. A method for creating an exfoliated nanotubes solution, aligning nanotubes and depositing them on a substrate or in matrix. In one embodiment, the method includes a nanocomposite of at least one nanotube electrostatically associated with at least one nanoplatelet. The nanoplatelets may be removed from the suspension by altering the ionic strength to create an exfoliated nanotube solution. The exfoliated nanotube solution for injection into microchannel templates and aligned deposition.

Abstract: The present invention an implantable, sub-cutaneous, bellows-like device with one plate proximal (or superficial) to the skin surface and the other plate distal (or deep) to the skin surface having a component of a pneumatic/hydrulic driver for an implantable medical device such as a cardiac assist, cardiac support, or combined cardiac assist and support device and inducible magnet material on the distal plate of the bellows that can be magnetically drawn towards the proximal plate by the action of a magnet outside the body to contract the bellows or pressurize the fluid in the bellows.

Abstract: Methods and systems for detecting binding between first and second molecules using a pH-sensitive fluorophore. A change in fluorescence emission intensity of the fluorophore is indicative of binding.

Abstract: A data processing apparatus is used for motion synthesis. A preprocessing unit of the data processing apparatus calculates a mixture of factor analysis (MFA) parameter by applying an energy minimized optimization algorithm to motion capture data acquired in advance and stored in a motion database (DB). When a motion probability distribution model is generated as described above, a calculating unit of the data processing apparatus synthesizes a motion corresponding to input motion sensing data by applying the input motion sensing data to the motion probability distribution model.

Abstract: A direct cardiac assist device which may aid in ventricular recovery. The device proactively modulates cardiac strain pattern to produce a contraction strain pattern that induces beneficial growth and remodeling of the myocardium or prevents or reduces apoptosis of the myocytes. The device may include an outer shell. membrane, or mesh and an inner membrane. The space between the outer member and the membrane may be filled with fluid that is pressurized during contraction. The device prescribes a beneficial strain pattern during heart contraction. This strain pattern does not invert the curvatures or grossly alter the curvatures of the heart and may assist in myocyte regrowth and healing of the failing heart.

Abstract: A processing apparatus for creating an avatar is provided. The processing apparatus calculates skeleton sizes of joints of the avatar and local coordinates corresponding to sensors attached to a target user, by minimizing a sum of a difference function and a skeleton prior function, the difference function representing a difference between a forward kinematics function regarding the joints with respect to reference poses of the target user and positions of the sensors, and the skeleton prior function based on statistics of skeleton sizes with respect to reference poses of a plurality of users.

Abstract: The present invention relates to systems and methods for dehumidifying air by establishing humidity gradients in one or more dehumidification units. Water vapor from relatively humid atmospheric air entering the dehumidification units is extracted by the dehumidification units without substantial condensation into low pressure water vapor vacuum volumes. For example, in one embodiment, the water vapor is extracted through water vapor permeable membranes of the dehumidification units into the low pressure water vapor vacuum volumes. As such, the air exiting the dehumidification units is less humid than the air entering the dehumidification units. The low pressure water vapor extracted from the air is compressed to a slightly higher pressure, condensed, and removed from the system at ambient conditions.